CERPOP • The BIOETHICS team

BIOETHICS - Trajectoires d'innovations en santé : enjeux bioéthiques et sociétaux

• Our work leads to outcomes such as the production of scenarios for the use of innovations in health care within a stabilized legal and ethical framework, an aid to validation and decision-making regarding clinical applications of innovations and the implications of innovative therapies for the health care system based on a multidisciplinary analysis.

• We develop tools and recommendations to facilitate data sharing, biological sample transfers and biotechnology governance. We produce methodologies to conduct ethical and legal frameworks that operate at a global scale.

 

BIOETHICS - Trajectoires d'innovations en santé : enjeux bioéthiques et sociétaux

• The bioethical dimension intersects with all our research axes:

1/ The governance of the body, its elements and its products: rights of individuals, ethical and public health issues (Taboulet F., Rial-Sebbag E., Cambon-Thomsen A., Chassang G. Duguet AM, Mabile L., Couderc B., Juillard-Condat B). This axis analyses the ethical, legal and social implications of medical/societal and research uses of the human body and the possible transformations or incorporations of these elements into health products (advanced therapy drugs). Specifically, we explore major bioethical issues related to the uses of the body and new disciplines of medicine.

2/ The uses of digital technology and scientific data (Béranger J., Rial-Sebbag E., Cambon-Thomsen A., Chassang G., Duguet AM, Mabile L.). Health data and more generally scientific data are nowadays produced in an unprecedented volume thanks to the development of digital tools. We intend to contribute to the implementation of an ethical data policy, whether the data are protected or open to the scientific community, by making the hypothesis that these ethical and legal issues of their use should be thought through upstream of the design of storage and processing tools (the so-called "by design" approach) and integrated into operating methods.

3/ The trajectories of actors in health care: evolutions and reconfigurations (Couderc B., Rial-Sebbag E., Julia S., Béranger J., Cambon-Thomsen A., Chassang G., Duguet AM, Taboulet F., Juillard-Condat B., Faya Robles B., Delpla PA). Public and private actors in the health sector are responsible for producing normative grey zones that underlie the use of innovations. These norms are the result of a social arbitration between the developers of new technologies and methods, and the users or end users. Our team is interested in the reconfiguration of these social spheres around innovation and how this contributes to the development of public policies at both the national and global levels.

BIOETHICS - Trajectoires d'innovations en santé : enjeux bioéthiques et sociétaux
Publications